Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Colorcon
McKinsey
Merck
Dow

Last Updated: June 26, 2022

Investigational Drug Information for Lurtotecan


✉ Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Lurtotecan?

Lurtotecan is an investigational drug.

There have been 6 clinical trials for Lurtotecan. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2001.

The most common disease conditions in clinical trials are Carcinoma, Ovarian Epithelial, Lung Neoplasms, and Head and Neck Neoplasms. The leading clinical trial sponsors are NCIC Clinical Trials Group, OSI Pharmaceuticals, and Astellas Pharma Inc.

Recent Clinical Trials for Lurtotecan
TitleSponsorPhase
Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung CancerOSI PharmaceuticalsPhase 2
Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung CancerAstellas Pharma IncPhase 2
Study of OSI-211 vs. Topotecan in Patients With Relapsed Epithelial Ovarian CancerOSI PharmaceuticalsPhase 2

See all Lurtotecan clinical trials

Clinical Trial Summary for Lurtotecan

Top disease conditions for Lurtotecan
Top clinical trial sponsors for Lurtotecan

See all Lurtotecan clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Colorcon
McKinsey
Merck
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.